January 10, 2012 -- Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing for the pharmaceutical and biotech industry, announced today that the company has been awarded $2 million by the State of New York Regional Economic Development Council. Norwich received the award based on the endorsement of the local Regional Council and the technical scoring of various state funding agencies.
“Norwich Pharmaceuticals is appreciative for the funding provided by the Governor’s Office and the Regional Economic Development Council,” said Terry Novak, president of Norwich Pharmaceuticals. “Community partnership has performed a critical role throughout the nearly 125 year history of Norwich Pharmaceuticals, and this funding will support our current efforts to expand capabilities and drive additional business into the Southern Tier.”
Funding received through the Regional Council will be applied to an expansion that includes equipment, surface area and staff. Once completed in 2012, the expansion will more than double Norwich Pharmaceuticals’ current capacity for pilot scale development and manufacturing.
About Norwich Pharmaceuticals
Norwich is a full-service contract development and manufacturing provider for Rx and OTC pharmaceuticals. Norwich applies more than 120 years of experience and an unparalleled compliance record to offer customers greater flexibility, resources and speed that result in a streamlined progression from product development to scale-up and commercial manufacturing through clinical services. Visit www.norwichpharma.com for additional information.